An important history of the development of cancer centers of excellence and the revolution in cancer treatment.

In the 1960s a coalition of concerned citizens, scientists and politicians joined forces to convince the federal government to focus its efforts on conquering cancer. The National Cancer Act of 1971 resulted and was signed into law on December 23, 1971 by President Nixon. The national War on Cancer, was declared with some leaders naively arguing that the disease would be conquered by the nations bicentenniala mere five years in the future.

Over the next five decades scientific discoveries demonstrated the great complexity of what had formerly been thought of as a single disease with the advent of the genetic characterization of cancers, it is now recognized that there are almost an infinite number of cancers as defined by their many genetic mutations. The National Cancer Act established the infrastructure for the designation of centers by the National Cancer Institute (NCI) and these centers have evolved into models of multidisciplinary, collaborative cancer research, treatment and prevention contributing to a reduction in cancer mortality and increase in quality of life and survival that has translated into more than 17 million cancer survivors in the United States in 2021.

Centers of the Cancer Universe: A Half-Century of Progress Against Cancer tells the story of how cancer research was not front and center at most universities and research institutions before the National Cancer Act of 1971, and why many physicians were reluctant even to treat patients with cancer in the early 20th century. It follows the behind-the-scenes lobbying, resistance and negotiating that preceded signing the Act into law, and how the cancer centers of today came to fruition, and shaped how cancer research, clinical trials and treatment would be conducted.

Donald L. Skip Trump, MD, has been an active clinician and investigator throughout his career in oncology. Prior to retiring from his position as founding CEO of the Inova Schar Cancer Institute (ISCI), in Fairfax, VA where he led development of large community health system cancer program, Trump was President and CEO of the Roswell Park Cancer Institute (RPCI), an NCI-designated cancer center. In addition to his 13-year career at RPCI, Trump held leadership positions at NCI centers at the University of Pittsburgh, Duke and the University of Wisconsin. He lives in Oakton, Virginia.

Eric T. Rosenthal is an award-winning independent journalist who has covered issues, controversies and trends in oncology for more than three decades for a number of news media outlets. He founded the National Cancer Institute-Designated Cancer Centers Public Affairs Network in 1990; has cochaired numerous conferences on cancer or medicine and the media; and served on several national cancer committees, including the NCI-Directors Consumer Liaison Group. He lives in Audubon, Pennsylvania.

Acknowledgements

Preface

Foreword by Nancy G. Brinker

Chapter 1-- The State of Cancer Research and Care: Before the National Cancer Act of 1971

Chapter 2-- Developing a National Cancer Program

Chapter 3-- Creating the Cancer Centers: The Legacy of the Yellow Berets

Chapter 4-- Building the Network of NCI-Designated Cancer Centers --A Few at a Time

Chapter 5-- The Newest Kids on the NCI-Designation Block

Chapter 6-- The Role of Pediatric Oncology and Pediatric Cancer Centers

Chapter 7-- Medicine or Marketing? Keeping True to the Mission and Balancing Hype and Hope

Chapter 8The Rise of Oncology Specialties and Professional Societies

Chapter 9-- Progress in Cancer Research and Cancer Care Since the National Cancer Act: According to the Experts

Chapter 10-- Where is the Best Place to Go When You Learn that You Have Cancer?

Chapter 11--Future Challenges for Cancer Centers: Funding and Finances, Community Cancer Centers, and Addressing Cancer Disparities

Bibliography

Notes

Index

About the Authors